The proposed bill, SB1211, amends existing Arizona law to allow pharmacists to dispense naloxone hydrochloride and other FDA-approved opioid antagonists without requiring a signed prescription. This change aims to enhance access to life-saving medications for individuals at risk of opioid overdose. Additionally, the bill eliminates the requirement for pharmacists to report specific prescription information related to the dispensing of these medications, as well as the need for the Arizona State Board of Pharmacy to establish dispensing protocols.

Furthermore, the bill increases the annual transfer limit from the Arizona State Board of Pharmacy Fund to the Poison and Drug Information Center from $500,000 to $1,000,000, allowing for greater funding support. It also exempts naloxone and other opioid antagonists from certain mislabeling or misbranding regulations when prescribed by healthcare practitioners. The bill is classified as an emergency measure, allowing it to take effect immediately upon the Governor's signature.

Statutes affected:
Introduced Version: 32-1968, 32-1979, 36-2608, 32-1921, 32-1967, 36-2266
Senate Engrossed Version: 32-1968, 32-1979, 36-2608, 32-1921, 32-1967, 36-2266
House Engrossed Version: 32-1907, 32-1968, 32-1979, 36-2608, 32-1939, 35-146, 35-147, 35-143.01, 36-2605, 36-1161, 32-1921, 32-1967, 36-2266
Chaptered Version: 32-1907, 32-1968, 32-1979, 36-2608, 32-1939, 35-146, 35-147, 35-143.01, 36-2605, 36-1161, 32-1921, 32-1967, 36-2266